Point72 (DIFC)’s Skye Bioscience SKYE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,865	Closed	-$30.8K	–	1543
2024 Q3	$30.8K	Buy	7,865 +1,865	+31%	+$7.29K	﹤0.01%	653
2024 Q2	$48.1K	Buy	+6,000	New	+$48.1K	﹤0.01%	565